SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001337553-21-000012
Filing Date
2021-11-05
Accepted
2021-11-04 18:18:00
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aeri-20210930.htm   iXBRL 10-Q 1433052
2 EX-10.1 aeri93021ex101.htm EX-10.1 61586
3 EX-31.1 aeri9302021ex311.htm EX-31.1 12475
4 EX-31.2 aeri9302021ex312.htm EX-31.2 12501
5 EX-32.1 aeri9302021ex321.htm EX-32.1 7298
6 EX-32.2 aeri9302021ex322.htm EX-32.2 7298
12 aeri-20210930_g1.jpg GRAPHIC 13447
13 aeri-20210930_g2.jpg GRAPHIC 13674
  Complete submission text file 0001337553-21-000012.txt   6458591

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20210930.xsd EX-101.SCH 38191
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20210930_cal.xml EX-101.CAL 65035
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20210930_def.xml EX-101.DEF 191311
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20210930_lab.xml EX-101.LAB 520709
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20210930_pre.xml EX-101.PRE 339509
14 EXTRACTED XBRL INSTANCE DOCUMENT aeri-20210930_htm.xml XML 1113994
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 211381529
SIC: 2836 Biological Products, (No Diagnostic Substances)